Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 40.00 | |
5 mg | In stock | $ 64.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 197.00 | |
50 mg | In stock | $ 328.00 | |
100 mg | In stock | $ 538.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 70.00 |
Description | LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell. |
Targets&IC50 | kallikrein:< 100 nM (EC50) |
Molecular Weight | 431.92 |
Formula | C24H22ClN5O |
CAS No. | 1801253-04-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 31.25 mg/mL (69.45 mM), ultrasonic and warming and heat to 60°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LSP-249 1801253-04-2 Others inhibit Serine proteases Inhibitor angioedema Ser/Thr Protease LSP249 Serine endopeptidases LSP 249 Threonine proteases inhibitor